aod9604 development discontinued AOD-9604 tested materials for laboratory and scientific research applications. AOD9604 - Pure Health Peptides
Description
As of 2025, AOD-9604 should be regarded as a discontinued research peptide, not a therapeutic agent , with ongoing relevance confined to academic and mechanistic exploration
Specific Evidence for No IGF-1 Effects: Blood samples collected at baseline and throughout the treatment period measured serum IGF-1 concentrations using validated immunoassays
AOD 9604 is not FDA-approved as a pharmaceutical drug
Frequently asked questions How fast will I see results with peptides
Isoleucine: Deters muscle degradation and accentuates recovery
